Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Powder 1.4 kcal/ml milkshake (0913021)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aymes Actajuni Shake powder 57g sachets banana milkshake
0913021J0BBABAB
|
Aymes powder 1.4 kcal/ml milkshake | Powder 1.4 kcal/ml milkshake (0913021) | Nutrition and Blood | 290 |
|
Aymes Actajuni Shake powder 57g sachets strawberry burst
0913021J0BBADAB
|
Aymes powder 1.4 kcal/ml milkshake | Powder 1.4 kcal/ml milkshake (0913021) | Nutrition and Blood | 265 |
|
Aymes Actajuni Shake powder 57g sachets classic chocolate
0913021J0BBACAB
|
Aymes powder 1.4 kcal/ml milkshake | Powder 1.4 kcal/ml milkshake (0913021) | Nutrition and Blood | 259 |
|
Aymes Actajuni Shake powder 57g sachets smooth vanilla
0913021J0BBAEAB
|
Aymes powder 1.4 kcal/ml milkshake | Powder 1.4 kcal/ml milkshake (0913021) | Nutrition and Blood | 185 |
|
Aymes Actajuni Shake powder 57g sachets simply neutral
0913021J0BBAFAB
|
Aymes powder 1.4 kcal/ml milkshake | Powder 1.4 kcal/ml milkshake (0913021) | Nutrition and Blood | 98 |
|
Aymes ActaJuni Shake Starter Pack powder
0913021J0BBAAAA
|
Aymes powder 1.4 kcal/ml milkshake | Powder 1.4 kcal/ml milkshake (0913021) | Nutrition and Blood | 17 |
|
Generic Aymes Actajuni Shake powder 57g sachets
0913021J0AAABAB
|
Powder 1.4 kcal/ml milkshake (0913021) | Powder 1.4 kcal/ml milkshake (0913021) | Nutrition and Blood | No data available |
|
Generic Aymes ActaJuni Shake Starter Pack powder
0913021J0AAAAAA
|
Powder 1.4 kcal/ml milkshake (0913021) | Powder 1.4 kcal/ml milkshake (0913021) | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.